AMGN · NASDAQ · Healthcare · Drug Manufacturers - General

Amgen

Past month
Price unavailable
  • 52W range269.77–447.03
  • P/E ratio27.14
  • Market cap233.78B

Latest news

Loading...

About

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and ora...

amgen.com